Live Breaking News & Updates on Endo Ventures

Stay updated with breaking news from Endo ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Catalyst Pharmaceuticals At A Crossroads: Firdapse Litigation And Agamree's Launch (CPRX)

Catalyst Pharmaceuticals At A Crossroads: Firdapse Litigation And Agamree's Launch (CPRX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United States , Coral Gables , New Jersey , Richard Daly , Teva Pharmaceuticals , Catalyst Pharmaceuticals , Catalyst Pharmaceuticals Inc , Endo Ventures , Santhera Pharmaceuticals , Assistance Program , Biomarin Pharmaceutical Inc , Lambert Eaton Syndrome , Biomarin Pharmaceutical , Endo Ventures Limited , Two Catalysts , Seeking Alpha ,

Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

/PRNewswire/ Endo International plc (OTC: ENDPQ) announced today that its subsidiary Endo Ventures Limited has executed an agreement with MAIA. ....

New Jersey , United States , Scott Sims , Endo Ventures , Prnewswire Endo International , Corporate Development , Endo International , Pharmaceuticals Inc , Exchange Commission , Injectable Solutions Generics At Endo , Endo Ventures Limited , Par Sterile Products , Senior Vice President , General Manager , Injectable Solutions , Brian Cooney , Note Regarding Forward Looking Statements , Private Securities Litigation Reform Act , Bankruptcy Code , Annual Report , Quarterly Reports , Endo International Plc ,

Endo International plc: Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

Only ready-to-use (RTU) liquid format of bivalirudin expected to begin shipping in summer 2023RTU bivalirudin injection does not require reconstitution, dilution or mixing, which helps increase ....

New Jersey , United States , Scott Sims , Gewinn Nur , Pharmaceuticals Inc , Exchange Commission , Endo Ventures , Corporate Development , Injectable Solutions Generics At Endo , Prnewswire Endo International , Endo Ventures Limited , Par Sterile Products , Senior Vice President , General Manager , Injectable Solutions , Brian Cooney , Private Securities Litigation Reform Act , Bankruptcy Code , Annual Report , Quarterly Reports ,

Endo International plc: Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension

DUBLIN, April 3, 2023 /PRNewswire/ Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the authorized generic ....

Merck Noxafil , Scott Sims , Endo International , Prnewswire Endo International , Injectable Solutions Generics At Endo , Merck Co Inc , Exchange Commission , Merck Sharp Dohme , Endo Ventures , Par Pharmaceutical , Senior Vice President , General Manager , Injectable Solutions , Endo Ventures Limited , Merck Sharp , Private Securities Litigation Reform Act , Bankruptcy Code , Annual Report , Quarterly Reports ,

Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension

/PRNewswire/ Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the. ....

Scott Sims , Merck Noxafil , Endo Ventures , Merck Sharp Dohme , Endo International , Injectable Solutions Generics At Endo , Exchange Commission , Prnewswire Endo International , Merck Co Inc , Par Pharmaceutical , Senior Vice President , General Manager , Injectable Solutions , Endo Ventures Limited , Merck Sharp , Private Securities Litigation Reform Act , Bankruptcy Code , Annual Report , Quarterly Reports , Endo International Plc ,